Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tedizolid Phosphate in Adolescents with cSSTI
NCT02276482Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tedizolid in acute bacterial skin and skin structure infection (ABSSSI), sponsored by Merck & Co.. Started Mar 2015; status: completed.
02
Drugs
tedizolid
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT02276482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02276482.